KIT and acute myeloid leukemia: In support of this model, pharmacologic inhibition of c-Kit with bortezomib in NOD/SCID mice transplanted with c-Kit mutant AML cells (FDC-P1/KITmut) abrogated c-Kit mRNA levels and increased miR-29b expression.